Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 103, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.intimp.2021.108434
Keywords
Daphnetin; Cornea; Neovascularization; Inflammation; Alkali-burn injury
Categories
Funding
- Natural Science Foundation of Fujian Province, China [2020J011037]
- National Natural Science Foundation of China [81774369]
Ask authors/readers for more resources
Research has shown that Daphnetin (DAP) can inhibit corneal inflammation and neovascularization caused by alkali burn. DAP acts by suppressing angiogenesis processes and the activation of downstream signaling molecules, and it can also alleviate the inflammatory response.
Alkali burn is a significant contributor to corneal injury. Alkali burn-induced corneal inflammation often causes vision loss due to corneal neovascularization. Daphnetin (DAP) has been studied for its anti-inflammatory and antiangiogenic properties with encouraging results. Driven by those encouraging results, we sought to explore the effects of DAP in treating alkali burn-induced corneal inflammation and neovascularization and its mechanism of action. We found that the angiogenesis processes of human umbilical vein endothelial cells (HUVECs) induced by vascular endothelial growth factor A (VEGF-A) were primarily attenuated by treatment with DAP, including proliferation, migration, and tube formation. Treatment of DAP significantly suppressed the VEGF-Ainduced protein expression of VEGF receptor2 (VEGFR2), as well as the activation of downstream signal transducer and activator of transcription 3 (STAT3), AKT, and extracellular signal-regulated kinase (ERK) signaling. In the mouse corneal alkali burn model, the inflammatory cell infiltrations and neovascularization in the cornea caused by alkali burn were inhibited by 10 mu M DAP eye drops. Alkali burn-induced corneal protein expression of VEGF-A, VEGFR2, phosphorylated (p-)STAT3, p-AKT, and p-ERK in corneal tissue were reduced mainly by DAP. Moreover, the upregulation of inflammatory caused by alkali burn in the pathological process was significantly neutralized by DAP. Mechanistically, the inflammatory response could be alleviated by DAP in the way of inhibiting the expression levels of TLR4, p-NF-kappa B, NLRP3, ASC, Cleaved-caspase-1 (p20), mature-IL-113 (p17), and N-GSDM. In conclusion, our findings confirmed that the corneal inflammation and neovascularization caused by alkali burn could be inhibited by DAP in vitro and in vivo, elucidating the underlying mechanisms of its protective effects. DAP may have tremendous therapeutic potential for the treatment of corneal alkali burn.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available